A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Radium 223 mCRPC-PEACE III
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
- Status
- COMPLETED
- Phase
- PHASE1
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men
- Status
- COMPLETED
- Phase
- PHASE1
Sequencing Abiraterone and Enzalutamide in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2